Skip to content

Brain Genomics Superstruct Project

Brain Genomics Superstruct Project

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01552460
Enrollment
61
Registered
2012-03-13
Start date
2011-04-30
Completion date
2015-01-31
Last updated
2024-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorders

Keywords

Autism Spectrum Disorders, Brain Imaging, Genetics

Brief summary

The purpose of this study is to explore the effects of genes and genetic variation on brain structure and function. Investigators at Harvard plan to explore the relationship between candidate genes that affect cognitive performance and brain structure/function. Since brain phenotypes reflect more proximal sequelae of gene activity, neuroimaging measures may show greater sensitivity than cognitive performance to measure gene effects.

Interventions

None listed

Sponsors

Harvard University
CollaboratorOTHER
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
13 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. 13 years or older 2. Subject must have a current DSM-IV diagnosis of high functioning ASD, based on past evaluations at the Bressler Clinic. 3. Subjects must have a level of understanding sufficient to communicate intelligently with the investigator and study coordinator, and to cooperate with all tests and examinations required by the protocol. 4. Each subject must understand the nature of the study. The subject must sign an IRB approved informed consent.

Exclusion criteria

1. IQ \< 70 bassed on evaluation in the Bressler Clinic. 2. Contraindication to MRI including presence of metal or surgical devices (plates, implants, braces or other items). 3. Neuropsychiatric conditions (such as dementia) which sufficiently impair cognition such that a surrogate consent would be required. 4. Neurological disorders associated with gross brain pathology (other than atrophy), e.g., stroke, tumors, or demyelinating diseases. 5. Pregnancy.

Design outcomes

Primary

MeasureTime frame
Neuroimaging phenotype1 day

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026